The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a severe hereditary disease caused by a lack of dystrophin, a protein essential for myocyte integrity. Mitochondrial dysfunction is reportedly responsible for DMD. This study examines the effect of glucocorticoid deflazacort on the functioning of the skeletal-mus...
Main Authors: | Mikhail V. Dubinin, Eugeny Yu. Talanov, Kirill S. Tenkov, Vlada S. Starinets, Natalia V. Belosludtseva, Konstantin N. Belosludtsev |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/22/8763 |
Similar Items
-
Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
by: Shefa Tawalbeh, et al.
Published: (2020-10-01) -
Outcome of Long-Term Corticosteroid Treatment in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01) -
Effect of the Non-Immunosuppressive MPT Pore Inhibitor Alisporivir on the Functioning of Heart Mitochondria in Dystrophin-Deficient <i>mdx</i> Mice
by: Mikhail V. Dubinin, et al.
Published: (2021-09-01) -
Ácido eicosapentanóico x deflazacorte : mecanismos de ação e comparação de efeitos no tratamento de camundongos mdx
by: Apolinário, Letícia Montanholi, 1988-
Published: (2012) -
Influence of Different Types of Corticosteroids on Heart Rate Variability of Individuals with Duchenne Muscular Dystrophy—A Pilot Cross Sectional Study
by: Rodrigo Martins Dias, et al.
Published: (2021-07-01)